Difficulty: Medium
Average Score: 81%
Practice
Primary malignancies with the highest cumulative incidence of a second neoplasm are
Correct answer
C
Rationale
The correct answer is C) Hodgkin disease. Patients with Hodgkin disease have a higher risk of developing a second neoplasm compared to other types of primary malignancies. This increased risk is attributed to various factors such as genetic predisposition, exposure to chemotherapy and radiotherapy, and impaired immune function.
Option A) Soft tissue sarcoma and Option B) Cancers of bone are less likely to have a high cumulative incidence of a second neoplasm compared to Hodgkin disease. Soft tissue sarcomas and bone cancers are primary malignancies that typically do not predispose individuals to the development of a second malignancy at the same rate as Hodgkin disease.
Option D) Leukemias, while also being primary malignancies, do not exhibit as high a risk for developing a second neoplasm compared to Hodgkin disease. The specific risk factors and biological mechanisms underlying the development of secondary neoplasms in leukemia patients differ from those in Hodgkin disease.
In an educational context, understanding the risk of second neoplasms in different primary malignancies is crucial for healthcare providers working with pediatric patients. This knowledge can inform surveillance strategies, survivorship care plans, and discussions with patients and their families about long-term health outcomes. It highlights the importance of considering individual cancer histories when managing pediatric oncology patients to provide comprehensive and personalized care.
Option A) Soft tissue sarcoma and Option B) Cancers of bone are less likely to have a high cumulative incidence of a second neoplasm compared to Hodgkin disease. Soft tissue sarcomas and bone cancers are primary malignancies that typically do not predispose individuals to the development of a second malignancy at the same rate as Hodgkin disease.
Option D) Leukemias, while also being primary malignancies, do not exhibit as high a risk for developing a second neoplasm compared to Hodgkin disease. The specific risk factors and biological mechanisms underlying the development of secondary neoplasms in leukemia patients differ from those in Hodgkin disease.
In an educational context, understanding the risk of second neoplasms in different primary malignancies is crucial for healthcare providers working with pediatric patients. This knowledge can inform surveillance strategies, survivorship care plans, and discussions with patients and their families about long-term health outcomes. It highlights the importance of considering individual cancer histories when managing pediatric oncology patients to provide comprehensive and personalized care.